HIV Vaccine Production
$1,029N01FY2012AINIH
Advanced Bioscience Laboratories, Inc., Kensington MD
Investigators
Abstract
This contract will provide for the production, scale-up, characterization and formulation of specific vaccine antigens and reagents as directed by the NIAID. In addition pilot lots of candidate vaccines will be produced under GLP/cGMPs appropriate for Phase I and Phase II human clinical trials.
View original record on NIH RePORTER →